Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,335.30 -19.12 -0.12%
S&P 500 1,666.29 -1.18 -0.07%
Nasdaq 3,496.43 -2.53 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,824.50 +6.51 0.23%
FTSE 100 6,755.63 +32.57 0.48%
DAX 8,455.83 +57.83 0.69%
Ticker Volume Price Price Delta
Nikkei 15,381.00 +20.21 0.13%
Hang Seng 23,389.10 -103.97 -0.44%
S&P/ASX 200 5,180.10 -28.94 -0.56%
BREAKING NEWS
Marks & Spencer Full-Year Pretax Profit Beats Estimates

Gevo Wins Appeals Court Ruling in Butamax Patent Dispute

Butamax Advanced Biofuels LLC, a joint venture of DuPont Co. and BP Plc (BP/), lost an appeals court bid to block Gevo Inc. (GEVO) from selling some of its biofuels products while a patent-infringement case is pending.

Gevo has raised “a substantial question of validity” of the Butamax patent, the U.S. Court of Appeals for the Federal Circuit said in upholding a judge’s decision not to issue a court ban. The court did say that U.S. District Judge Sue Robinson in Wilmington, Delaware should reconsider her interpretation of the patent. The case is part of a broader dispute between the two companies over genetically engineered microorganisms used to produce biofuels.

To contact the reporter on this story: Susan Decker in Washington at sdecker1@bloomberg.net

To contact the editor responsible for this story: Bob Drummond at bdrummond@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link